COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,845 Articles (22,553 medRxiv, 8,292 bioRxiv)

Most recent first Previous |  Page 2182: Articles 21811-21820  | Next

Modeling and Forecasting of COVID-19 New Cases in the Top 10 Infected African Countries Using Regression and Time Series Models
Argawu, A.
10.1101/2020.09.23.20200113 — Posted: 2020-09-24
Performance Assessment of First-Generation AntiSARS-CoV-2 Serological Assays
Shamsi, T. S., Imam, M., Khawaja, S., Naz, A., Siddiqi, A. Q., Nafees, T. S., Younas, A., Shamsi, U., Shabir, I., Ahmed, S., Tariq, N., Tariq, S.
10.1101/2020.09.22.20197046 — Posted: 2020-09-24
Comparative Effectiveness of Famotidine in Hospitalized COVID-19 Patients
Shoaibi, A., Fortin, S., Weinstein, R., Berlin, J., Ryan, P.
10.1101/2020.09.23.20199463 — Posted: 2020-09-24
Epidemiological measures for informing the general public during the SARS-CoV-2-outbreak: simulation study about bias by incomplete case-detection
Brinks, R., Kuechenhoff, H., Timm, J., Kurth, T., Hoyer, A.
10.1101/2020.09.23.20200089 — Posted: 2020-09-24
Prospective comparison of saliva and nasopharyngeal swab sampling for mass screening for COVID-19
COVISAL Guyane, , nacher, m., demar, m.
10.1101/2020.09.23.20150961 — Posted: 2020-09-24
Risk factors for mortality among hospitalized patients with COVID-19
Incerti, D., Rizzo, S., Li, X., Lindsay, L., Yau, V., Keebler, D., Chia, J., Tsai, L.
10.1101/2020.09.22.20196204 — Posted: 2020-09-24
A proof of concept for neutralizing antibody-guided vaccine design against SARS-CoV-2
Zhang, L., Cao, L., Gao, X., Zheng, B., Deng, Y., Li, J.-X., Feng, R., Bian, Q., Guo, X.-L., Wang, N., Qiu, H.-Y., Wang, L., Cui, Z., Ye, Q., Chen, G., Lu, K.-K., Chen, Y., Chen, Y.-T., Pan, H.-X., Zhu, B.-L., Qin, C.-F., Wang, X., Zhu, F.-C.
10.1101/2020.09.23.309294 — Posted: 2020-09-23
Establishment of a reverse genetics system for SARS-CoV-2 using circular polymerase extension reaction
Torii, S., Ono, C., Suzuki, R., Morioka, Y., Anzai, I., Fauzyah, Y., Maeda, Y., Kamitani, W., Fukuhara, T., Matsuura, Y.
10.1101/2020.09.23.309849 — Posted: 2020-09-23
Respiratory disease in cats associated with human-to-cat transmission of SARS-CoV-2 in the UK
Hosie, M. J., Epifano, I., Herder, V., Orton, R., Stevenson, A., Johnson, N., MacDonald, E., Dunbar, D., McDonald, M., Howie, F., Tennant, B., Herrity, D., Filipe, A. C., Streicker, D. G., Willett, B. J., Murcia, P. R., Jarrett, R. F., Robertson, D. L., Weir, W., COVID-19 Genomics UK Consortium
10.1101/2020.09.23.309948 — Posted: 2020-09-23
Cross-reactive serum and memory B cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection
Song, G., He, W.-t., Callaghan, S., Anzanello, F., Huang, D., Ricketts, J., Torres, J. L., Beutler, N., Peng, L., Vargas, S., Cassell, J., Parren, M., Yang, L., Ignacio, C., Smith, D. M., Voss, J. E., Nemazee, D., Ward, A. B., Rogers, T., Burton, D. R., Andrabi, R.
10.1101/2020.09.22.308965 — Posted: 2020-09-23

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).